GLP-3 15mg vial

For laboratory research only. Not for human or veterinary consumption.

GLP-3 15mg vial contains retatrutide, supplied as a research material with a nominal content of 15 mg per vial.

Batch test results

Independent Janoshik testing of batch 013 is available below. Report #221585, dated 23 August 2026, measured 16.85 mg of retatrutide and 99.219% purity in the tested sample.

Heavy-metal screening report #221586, dated 19 August 2026, recorded arsenic, cadmium, lead and mercury as not detected in the tested sample. See the original certificates for the full results.

For in vitro laboratory research use only. Not for human or veterinary use. Not intended for diagnosis, treatment or prevention of disease.